Oral candidiasis in HIV-uninfected pediatric population in areas with limited fungal diagnosis: A case study from a tertiary hospital, Tanzania
- PMID: 34094534
- PMCID: PMC8141982
- DOI: 10.1177/20499361211016964
Oral candidiasis in HIV-uninfected pediatric population in areas with limited fungal diagnosis: A case study from a tertiary hospital, Tanzania
Abstract
Background: Oral candidiasis (OC) is an indirect indicator of cell-mediated immunodeficiency with a high predictive value of disseminated candidiasis. Here, we report the prevalence and factors associated with laboratory-confirmed OC in human immunodeficiency virus (HIV)-uninfected children with clinical OC attending the outpatient clinic or admitted in pediatric wards of the Bugando Medical Center (BMC).
Methods: A cross-sectional study was conducted between January and June 2017. Social demographic and clinical data were collected using a pre-tested data collection tool. Oral swabs were collected using a sterile cotton swab and mycological culture was done to detect Candida spp. followed by susceptibility testing as per European Committee on Antimicrobial Testing (EUCAST) guidelines. Data were analyzed using STATA version 13 following study objectives.
Results: A total of 325 non-repetitive oral swabs from HIV-uninfected children aged between 2 and 156 months were collected. Candida spp. were detected in 123 (37.8%) children. One (1.8%) C. albicans isolate was resistant to fluconazole, voriconazole, and posaconazole with minimum inhibitory concentrations (MIC) of 256 μg/ml, 32 μg/ml, and 0.31 μg/ml, respectively. Upon multivariate logistic regression analysis, being a male child (OR 2, 95% CI 1.2-3.2, p = 0.008) and having a history of antibiotic use (OR 1.8, 95% CI 1.1-2.8, p = 0.017) independently predicted laboratory-confirmed OC among HIV-uninfected children.
Conclusion: Only a third of children with clinical OC were laboratory confirmed, and this was more likely in male children with a history of antibiotic use. Most of the isolates were highly susceptible to commonly used antifungal agents like fluconazole. Treatment of children at risk should be prioritized to reduce associated morbidity.
Keywords: Antibiotic use; C. albicans; Limited fungi diagnosis; oral candidiasis.
© The Author(s), 2021.
Conflict of interest statement
Conflict of interest statement: The authors declare that there is no conflict of interest.
Figures
Similar articles
-
Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.BMC Pregnancy Childbirth. 2020 May 6;20(1):266. doi: 10.1186/s12884-020-02963-3. BMC Pregnancy Childbirth. 2020. PMID: 32375724 Free PMC article.
-
Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.AIDS. 1994 Jul;8(7):945-50. doi: 10.1097/00002030-199407000-00011. AIDS. 1994. PMID: 7946104
-
Fungal Profile of Vulvovaginal Candidiasis in a Tertiary Care Hospital.J Clin Diagn Res. 2017 Mar;11(3):DC06-DC09. doi: 10.7860/JCDR/2017/23578.9475. Epub 2017 Mar 1. J Clin Diagn Res. 2017. PMID: 28511380 Free PMC article.
-
Oral candidiasis among African human immunodeficiency virus-infected individuals: 10 years of systematic review and meta-analysis from sub-Saharan Africa.J Oral Microbiol. 2017 Jun 21;9(1):1317579. doi: 10.1080/20002297.2017.1317579. eCollection 2017. J Oral Microbiol. 2017. PMID: 28748027 Free PMC article. Review.
-
Candida and candidaemia. Susceptibility and epidemiology.Dan Med J. 2013 Nov;60(11):B4698. Dan Med J. 2013. PMID: 24192246 Review.
Cited by
-
Fungal diseases in Africa: epidemiologic, diagnostic and therapeutic advances.Ther Adv Infect Dis. 2022 Mar 4;9:20499361221081441. doi: 10.1177/20499361221081441. eCollection 2022 Jan-Dec. Ther Adv Infect Dis. 2022. PMID: 35281765 Free PMC article. No abstract available.
References
-
- Wilcox CM, Straub RF, Clark WS. Prospective evaluation of oropharyngeal findings in human immunodeficiency virus-infected patients with esophageal ulceration. Am J Gastroenterol 1995; 90: 1938–1941. - PubMed
-
- Thanyasrisung P, Kesakomol P, Pipattanagovit P, et al.. Oral Candida carriage and immune status in Thai human immunodeficiency virus-infected individuals. J Med Microbiol 2014; 63: 753–759. - PubMed
-
- Fong IW, Manuel L, Burford-Mason A. Asymptomatic oral carriage of Candida albicans in patients with HIV infection. Clin Invest Med 1997; 20: 85–93. - PubMed
-
- Mushi MF, Mtemisika CI, Bader O, et al.. High oral carriage of non-albicans Candida spp. among HIV-infected individuals. Int J Infect Dis 2016; 49: 185–188. - PubMed
-
- Walsh T, Butler K. Fungal infections complicating pediatric AIDS. In: Wilfert C, Pizzo PA. (eds) Pediatric AIDS: the challenge of HIV infection in infants, children, and adolescents. Baltimore, MD: The Williams & Wilkins Co, 1991, pp.225–244.
LinkOut - more resources
Full Text Sources
Miscellaneous
